Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 14 Show results per page	View Search Criteria \| Help With Results


1.		Phase III Study of L-PAM vs P-32 and Persantine plus Aspirin vs Placebo for Thrombocytic Myeloproliferative Disorders

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				30 and over								PVSG-10


2.		Phase III Chemotherapy with Fluoxymesterone, Oxymetholone, Testosterone and Splenectomy for Myeloproliferative Disorders and Refractory Anemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Completed				no age specified								PVSG-2


3.		Phase III Melphalan Chemotherapy vs Intraperitoneal Radioactive Chromic Phosphate for Stage I Epithelial Ovarian Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				GOG-46 GOG-7862

Last Modified: 7/1/1993


4.		Phase III Comparison of Venesection, Radiophosphorus, and Busulphan Chemotherapy in the Treatment of Polycythemia Vera (Summary Last Modified 07/93)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				over 35								MRC-LEUK-PRV EU-92019, UICC-73057, UKM-MRC-PT-7357

Last Modified: 3/21/2008


5.		Phase III Randomized Comparison of Intraperitoneal 32-P vs Combination Chemotherapy with CDDP/CTX as Adjuvant Therapy Following Complete Resection of Ovarian Carcinoma with Pelvic Extension or of Unfavorable Histology

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				18 to 75				NCI				GOG-95 MAYO-876102, NCCTG-876102, NCI-87-C-12, SWOG-9047, NCI-T87-0051N, T87-0051

Last Modified: 7/22/2004


6.		Phase III Randomized Evaluation of Adjuvant Intraperitoneal 32-P Following Negative Second-Look Laparotomy in Patients with Stage III Epithelial Ovarian Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				NCI				GOG-93 NCCTG-896151, GOG-0093

Last Modified: 5/15/2007


7.		Phase III Chemotherapy with CLB/PRED and CTX/ARA-C/PRED vs Total Body Radiotherapy for Chronic Lymphocytic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified				NCI				EST-3476

Last Modified: 3/19/2007


8.		Phase I/II Study of Intratumoral Infusion of Colloidal 32-P Followed by Conventional Chemoradiotherapy for Unresectable Pancreatic Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over								CH/UMC-9210 NCI-V94-0454

Last Modified: 2/1/2001 First Published: 7/1/2000


9.		Phase I/II Study of Interstitial Colloidal Phosphorus P32 and Macroaggregated Albumin in Patients With Locally Recurrent Prostate Cancer That Has Failed Conventional Therapy (Summary Last Modified 02/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				21 and over				Other				CMM-99025 NCI-V00-1585, NCT00005939

Last Modified: 6/13/2007


10.		Phase II Study of Interstitial Colloidal Phosphorus P32 Integrated Into the Treatment of Patients With Unresectable Pancreatic Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				Other				CMM-95079 CH/UMC-95079, NCI-V95-0760, NCT00002689

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute